Results 1 to 10 of about 4,339 (195)

The Protective Effects of Bushen Daozhuo Granule on Chronic Non-bacterial Prostatitis [PDF]

Frontiers in Pharmacology, 2023
Background: Chronic non-bacterial prostatitis (CNP), one of the most common chronic diseases in urology, leads to pain in the prostate and dysuria, critically affecting the physical or mental health of patients.
Dalin Sun, Dong Xing, Dandan Wang, Yuanyuan Liu, Bin Cai, Weimin Deng, Qinglin Hu, Wenjun Ma, Baofang Jin   +8 more
doaj   +6 more sources

Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: A systematic review and meta-analysis. [PDF]

PLoS ONE, 2020
PurposeChronic pelvic pain syndrome (CPPS) is one of the most common outpatient urological diagnoses, and its incidence is increasing. Extracorporeal shockwave therapy (ESWT) has been suggested for relieving local perineal symptoms associated with ...
Ponco Birowo, Ervandy Rangganata, Nur Rasyid, Widi Atmoko   +3 more
doaj   +5 more sources

High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome.

PLoS ONE, 2011
BackgroundAlthough prostatitis syndrome (PS) and irritable bowel syndrome (IBS) are common disorders, information on the prevalence of IBS in infertile patients with PS is relatively scanty.
Enzo Vicari, Sandro La Vignera, Domenico Arcoria, Rosita Condorelli, Lucia O Vicari, Roberto Castiglione, Andrea Mangiameli, Aldo E Calogero   +7 more
doaj   +4 more sources

Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome. [PDF]

J Cell Mol Med, 2021
AbstractQianliexin capsule (QLX) is a standardized traditional Chinese herbal preparation that has long been used to treat chronic non‐bacterial prostatitis (CNP) and benign prostatic hyperplasia (BPH). This study investigated the anti‐inflammatory activity of QLX in improving lower urinary tract symptoms (LUTS) associated with CNP and BPH.
Zang L, Tian F, Yao Y, Chen Y, Shen Y, Han M, Meng Z, Fan S, Zhang X, Cai T, Gao Q, Zhang Y, Lu J.   +12 more
europepmc   +5 more sources

Overexpression of lncRNA GAS5 suppresses prostatic epithelial cell proliferation by regulating COX-2 in chronic non-bacterial prostatitis. [PDF]

Cell Cycle, 2019
Chronic non-bacterial prostatitis (CNP) is a common urologic disease that is linked to the development of prostate cancer. Long non-coding RNA (lncRNA) GAS5 has been identified to mediate cell proliferation in prostate cancer, although its role in CNP is still unclear.
Xu X, Hou J, Lv J, Huang Y, Pu J, Wang L.   +5 more
europepmc   +5 more sources

Multi-Omics Analysis Reveals Changes in the Intestinal Microbiome, Transcriptome, and Methylome in a Rat Model of Chronic Non-bacterial Prostatitis: Indications for the Existence of the Gut-Prostate Axis [PDF]

Frontiers in Physiology, 2022
Chronic non-bacterial prostatitis (CNP) is one of the most prevalent diseases in human males worldwide. In 2005, the prostate-gut axis was first proposed to indicate the close relationship between the prostate and the intestine.
Junsheng Liu, Junsheng Liu, Yihe Wang, Guangwen Zhang, Liu Liu, Xichun Peng   +5 more
doaj   +2 more sources

Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis [PDF]

Journal of Nanobiotechnology
Background The complex etiology and pathogenesis underlying Chronic Non-Bacterial Prostatitis (CNP), coupled with the existence of a Blood Prostate Barrier (BPB), contribute to a lack of specificity and poor penetration of most drugs.
Yan Ye, Wenzhen Zhong, Ruifeng Luo, Hongzhi Wen, Ziyang Ma, Shanshan Qi, Xiaoqin Han, Wenbiao Nie, Degui Chang, Runchun Xu, Naijing Ye, Fei Gao, Peihai Zhang   +12 more
doaj   +2 more sources

Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review [PDF]

Infectious Diseases and Therapy
Background Effective treatment of bacterial prostatitis is limited by poor antibiotic penetration into prostatic tissue due to anatomical and physiological barriers, including the blood–prostate barrier, pH-dependent ion trapping, and protein binding ...
Rui Ge, Xinwen Nian, Benjuan Liu, Yunyun Yang, Zhuo Wang   +4 more
doaj   +2 more sources

Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin. [PDF]

Int J Urol
ABSTRACT Objectives To compare the effectiveness and safety of two antibiotic prophylaxis regimens, ciprofloxacin plus gentamicin and ceftriaxone plus cefixime, in preventing infectious complications after transrectal ultrasound‐guided prostate biopsy.
Balık AY, Ediz E, Ayvacık B, Taşkıran AT, Başaran E, Baba D.   +5 more
europepmc   +2 more sources

Three-Glass Test to Culture Prostate Secretion and Semen of Chronic Prostatitis Patients [PDF]

Diagnostics
Background/Objectives: Currently, the Meares–Stamey 4-glass and the 2-glass tests are used for diagnosing chronic prostatitis subtypes. Both tests include prostatic massage.
Konstantinos Stamatiou, Hippocrates Moschouris, Konstantinos Tzelepis, Gianpaolo Perletti, Vittorio Magri   +4 more
doaj   +2 more sources